D-2HG levels in plasma of tumor-bearing mice were not altered (data not shown) which is in agreement with the recent finding that plasma levels of D-2HG do not correlate with IDH1-mutation status in glioma patients [46]. This evidence concerns the gene IDH1 and central nervous system cancer.